Caribou Biosciences logo

Caribou Biosciences

CRBU | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.04 (-8.03%)
At close: Oct 26, 2026, 4:00 PM ET
-8.03%

Rating

Updated: Oct 22, 2026
27.5
-1.5 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $52.77M
1D Range
0.49 0.54
52W Range
0.46 2.50

Valuation (TTM)

PE -0.45
PB 0.54
EV/EBITDA 0.32

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $1.00
Loading financial charts...

Profile

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address b...

Sector Healthcare
Industry Biotechnology
Employees 97
IPO Date Jul 23, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
7
Consensus
Hold
Price Target
$1.00
Upside
+104.08%
Buy (3)
Hold (4)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.